Stockreport

Rigel Pharmaceuticals Inc (RIGL) Reports Growth in 2023 Sales, Despite Net Loss for the Year [Yahoo! Finance]

Rigel Pharmaceuticals, Inc.  (RIGL) 
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.rigel.com
PDF Revenue Growth : Total revenues of $116.9 million in 2023, with a significant increase in REZLIDHIA net product sales. Costs and Expenses : Decreased to $137.4 millio [Read more]